Estimated reading time: 6 minutes Key Takeaways Revvity’s Q1 FY2025 earnings report exceeded market predictions. Significant revenue growth and profitability improvements. Investors gained renewed confidence in the company’s stock performance. …
-
-
Estimated reading time: 6 minutes Key Takeaways Tariffs on building materials are driving up UK home insurance costs The cost of repairing or rebuilding homes is higher Some regions may …
-
Estimated reading time: 7 minutes Key Takeaways EBS revolutionised forex markets by introducing a transparent spot FX trading platform. Private trading on EBS protects identities of large-scale traders. Offers strong …
-
Estimated reading time: 5 minutes Key Takeaways IBM unveils a bold £150 billion plan focused on American tech leadership. Key priorities include quantum computing, artificial intelligence, and US manufacturing. Arvind …
-
Estimated reading time: 5 minutes Key Takeaways Insulet has named Ashley McEvoy as its new CEO, targeting enhanced revenue growth. Leadership transition aims to accelerate innovation and expand market share …
-
Estimated reading time: 7 minutes Key Takeaways The El Salvador Colón (SVC) was the country’s currency from 1892 to 2001, leaving a lasting imprint on its economy. Its transition to …
-
Estimated reading time: 7 minutes Key Takeaways Crude oil inventories serve as a barometer for global supply-demand balance and can foreshadow potential price shifts. EIA Weekly Report (EIA Weekly Report) …
-
Estimated reading time: 6 minutes Key Takeaways Today’s U.S. stock market is operational on Monday, 28 April 2025, with no holidays or early closures. Major earnings reports and key economic …
-
Estimated reading time: 7 minutes Key Takeaways Domino’s Q1 2025 revenue rose by 2.5% despite US sales challenges. Net income surged by 18.9%, underscoring strong profitability. International markets counterbalanced domestic …
-
Estimated reading time: 5 minutes Key Takeaways Merck KGaA acquires SpringWorks Therapeutics for $3.9 billion. The acquisition boosts Merck’s rare cancer drug portfolio. SpringWorks Therapeutics brings innovative therapies, including Ogsiveo. …